“培土生金”法治疗慢性阻塞性肺疾病的理论与机制研究进展
Progress in Research on the Theory and Mechanisms of the “Earth-Reinforcing to Generate Metal” Method in Treating COPD
摘要: 慢性阻塞性肺疾病(Chronic obstructive pulmonary disease, COPD)是临床高发的慢性呼吸系统疾病，以进行性不可逆气流受限为主要特征，病情反复、预后较差，全球疾病负担严峻。中医药凭借整体调治、标本兼顾的优势，在COPD稳定期干预中独具特色。现代研究证实，该治法可调控炎症通路、抑制气道黏液高分泌、减轻氧化应激、阻断气道重塑并平衡机体免疫，有效改善患者临床症状、提升生活质量、减少急性发作。本文综述“培土生金”法治疗COPD的中医理论、现代机制研究进程，以期为该治法的深入研究与临床推广提供参考。
Abstract: Chronic obstructive pulmonary disease (COPD) is a prevalent chronic respiratory disease characterized by progressive and irreversible airflow limitation, with recurrent episodes and poor prognosis, imposing a severe global disease burden. Traditional Chinese medicine exhibits unique advantages in the intervention of stable COPD due to its holistic regulation and simultaneous treatment of root causes and symptoms. Modern studies have verified that this therapy can regulate inflammatory pathways, inhibit airway mucus hypersecretion, alleviate oxidative stress, block airway remodeling, and balance immune function, thereby effectively ameliorating clinical symptoms, improving patients’ quality of life, and reducing acute exacerbations. This paper systematically reviews the TCM theoretical connotation and modern mechanism research progress of the “earth-reinforcing to generate metal” therapy in the treatment of COPD, aiming to provide references for its in-depth research and clinical promotion.
文章引用：李俊奇, 刘亦琳, 梁繁荣. “培土生金”法治疗慢性阻塞性肺疾病的理论与机制研究进展[J]. 中医学, 2026, 15(10): 141-147. https://doi.org/10.12677/tcm.2026.1510536

参考文献

[1] 《中成药治疗优势病种临床应用指南》标准化项目组. 中成药治疗慢性阻塞性肺疾病临床应用指南(2021年) [J]. 中国中西医结合杂志, 2022, 42(8): 901-914.
[2] 王凤燕, 张冬莹, 梁振宇, 等. 面向全科医生的《慢性阻塞性肺疾病诊治指南(2021年修订版)》解读[J]. 中国全科医学, 2021, 24(29): 3660-3663, 3677.
[3] 杨柳柳, 刘小虹, 詹少锋, 等. 肺康颗粒通过TLR4/NF-κB信号通路干预COPD大鼠炎症的相关机制[J]. 中药新药与临床药理, 2018, 29(6): 687-692.
[4] Yang, L., Wen, M., Liu, X., Wang, K. and Wang, Y. (2020) Feikang Granules Ameliorate Pulmonary Inflammation in the Rat Model of Chronic Obstructive Pulmonary Disease via TLR2/4-Mediated NF-κB Pathway. BMC Complementary Medicine and Therapies, 20, Article No. 170.
https://doi.org/10.1186/s12906-020-02964-x
[5] Hu, X., Hong, B. and Sun, M. (2022) Peitu Shengjin Recipe Attenuates Airway Inflammation via the TLR4/NF-κB Signaling Pathway on Chronic Obstructive Pulmonary Disease. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID: 2090478.
https://doi.org/10.1155/2022/2090478
[6] 王胜, 熊玲玲, 任薇, 等. 益肺健脾方对慢性阻塞性肺疾病模型大鼠气道炎症和气道黏液高分泌的影响[J]. 中国中西医结合杂志, 2015, 35(8): 993-999.
[7] Stylianou, P., Clark, K., Gooptu, B., Smallwood, D., Brightling, C.E., Amrani, Y., et al. (2019) Tensin1 Expression and Function in Chronic Obstructive Pulmonary Disease. Scientific Reports, 9, Article No. 18942.
https://doi.org/10.1038/s41598-019-55405-2
[8] 李配, 邓秀兰, 钟相根, 等. 健脾益肺化痰方对慢性阻塞性肺疾病模型大鼠肺组织病理的影响[J]. 中华中医药学刊, 2015, 33(6): 1330-1332.
[9] 杨晓敏, 刘娟, 赵娜妹, 等. 健脾益肺化痰方通过抑制IL-13信号通路改善COPD大鼠气道黏液高分泌[J]. 中华中医药学刊, 2016, 34(8): 1904-1907.
[10] 赵娜妹, 邓秀兰, 刘娟, 等. 健脾益肺化痰方对慢性阻塞性肺疾病大鼠胃肠动力及排痰量的影响[J]. 中华中医药学刊, 2016, 34(7): 1634-1636.
[11] Rogers, L.K. and Cismowski, M.J. (2018) Oxidative Stress in the Lung—The Essential Paradox. Current Opinion in Toxicology, 7, 37-43.
https://doi.org/10.1016/j.cotox.2017.09.001
[12] Rahman, I. and Adcock, I.M. (2006) Oxidative Stress and Redox Regulation of Lung Inflammation in COPD. European Respiratory Journal, 28, 219-242.
https://doi.org/10.1183/09031936.06.00053805
[13] Dailah, H.G. (2022) Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review. Molecules, 27, Article 5542.
https://doi.org/10.3390/molecules27175542
[14] Rahman, I. (2005) The Role of Oxidative Stress in the Pathogenesis of COPD: Implications for Therapy. Treatments in Respiratory Medicine, 4, 175-200.
https://doi.org/10.2165/00151829-200504030-00003
[15] 林琳, 于旭华, 许银姬, 等. 健脾益肺Ⅱ号对熏烟联合脂多糖诱导大鼠肺组织氧化/抗氧化失衡的调节及超微结构的影响[J]. 南京中医药大学学报, 2015, 31(1): 39-43.
[16] 田燕歌, 李亚, 李建生, 等. 调补肺肾三法对慢性阻塞性肺疾病大鼠肺组织氧化应激的影响和远后效应[J]. 中华中医药杂志, 2014, 29(2): 621-624.
[17] Kicic, A., Hallstrand, T.S., Sutanto, E.N., Stevens, P.T., Kobor, M.S., Taplin, C., et al. (2010) Decreased Fibronectin Production Significantly Contributes to Dysregulated Repair of Asthmatic Epithelium. American Journal of Respiratory and Critical Care Medicine, 181, 889-898.
https://doi.org/10.1164/rccm.200907-1071oc
[18] Aldonyte, R., Bagdonas, E., Raudoniute, J. and Bruzauskaite, I. (2015) Novel Aspects of Pathogenesis and Regeneration Mechanisms in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 10, 995-1013.
https://doi.org/10.2147/copd.s82518
[19] Hirota, N. and Martin, J.G. (2013) Mechanisms of Airway Remodeling. Chest, 144, 1026-1032.
https://doi.org/10.1378/chest.12-3073
[20] Su, X., Wu, W., Zhu, Z., Lin, X. and Zeng, Y. (2022) The Effects of Epithelial-Mesenchymal Transitions in COPD Induced by Cigarette Smoke: An Update. Respiratory Research, 23, Article No. 225.
https://doi.org/10.1186/s12931-022-02153-z
[21] Gueders, M.M., Foidart, J., Noel, A. and Cataldo, D.D. (2006) Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of MMPs in the Respiratory Tract: Potential Implications in Asthma and Other Lung Diseases. European Journal of Pharmacology, 533, 133-144.
https://doi.org/10.1016/j.ejphar.2005.12.082
[22] 李亚, 王英, 李建生, 等. 调补肺肾三法对慢性阻塞性肺疾病大鼠肺组织MMP-2、MMP-9和TIMP-1mRNA的影响及远后效应[J]. 中华中医药杂志, 2014, 29(1): 91-94.
[23] 李亚, 王元元, 李建生, 等. 调补肺肾法对COPD大鼠肺组织胶原和基质金属蛋白酶的影响及远后效应[J]. 北京中医药大学学报, 2012, 35(9): 615-619.
[24] 黄少君, 傅汝梅. 培土生金方对慢性阻塞性肺疾病稳定期患者气道重塑机制的观察[J]. 中国实验方剂学杂志, 2018, 24(1): 174-179.
[25] Li, Y., Li, J.S., Li, W.W., Li, S.Y., Tian, Y.G., Lu, X.F., et al. (2014) Long-Term Effects of Three Tiao-Bu Fei-Shen Therapies on NF-κB/TGF-β1/Smad2 Signaling in Rats with Chronic Obstructive Pulmonary Disease. BMC Complementary and Alternative Medicine, 14, Article No. 140.
https://doi.org/10.1186/1472-6882-14-140
[26] 曹福凯, 郭建辉, 梁栋, 等. 健脾益肺口服液对慢阻肺“肺脾气虚证”大鼠免疫功能的影响[J]. 中成药, 2014, 36(10): 2184-2186.
[27] Keely, S. and Hansbro, P.M. (2014) Lung-Gut Cross Talk: A Potential Mechanism for Intestinal Dysfunction in Patients with COPD. Chest, 145, 199-200.
https://doi.org/10.1378/chest.13-2077
[28] Vaughan, A., Frazer, Z.A., Hansbro, P.M. and Yang, I.A. (2019) COPD and the Gut-Lung Axis: The Therapeutic Potential of Fibre. Journal of Thoracic Disease, 11, S2173-S2180.
https://doi.org/10.21037/jtd.2019.10.40
[29] De Nuccio, F., Piscitelli, P. and Toraldo, D.M. (2022) Gut-Lung Microbiota Interactions in Chronic Obstructive Pulmonary Disease (COPD): Potential Mechanisms Driving Progression to COPD and Epidemiological Data. Lung, 200, 773-781.
https://doi.org/10.1007/s00408-022-00581-8
[30] Macia, L., Tan, J., Vieira, A.T., Leach, K., Stanley, D., Luong, S., et al. (2015) Metabolite-Sensing Receptors GPR43 and GPR109A Facilitate Dietary Fibre-Induced Gut Homeostasis through Regulation of the Inflammasome. Nature Communications, 6, Article No. 6734.
https://doi.org/10.1038/ncomms7734
[31] Anand, S. and Mande, S.S. (2018) Diet, Microbiota and Gut-Lung Connection. Frontiers in Microbiology, 9, Article 2147.
https://doi.org/10.3389/fmicb.2018.02147
[32] Mao, J., Li, Y., Bian, Q., Xuan, Y., Li, J., Wang, Z., et al. (2022) The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats. International Journal of Chronic Obstructive Pulmonary Disease, 17, 1285-1298.
https://doi.org/10.2147/copd.s359428
[33] Hassett, D.J., Borchers, M.T. and Panos, R.J. (2014) Chronic Obstructive Pulmonary Disease (COPD): Evaluation from Clinical, Immunological and Bacterial Pathogenesis Perspectives. Journal of Microbiology, 52, 211-226.
https://doi.org/10.1007/s12275-014-4068-2
[34] 姜素丽, 李亚, 田燕歌, 等. 调补肺肾三法对COPD大鼠T淋巴细胞亚群及CD4+CD25+的影响及远后效应[J]. 中国中西医结合杂志, 2013, 33(11): 1538-1544.
[35] Tan, D., Yin, W., Guan, F., Zeng, W., Lee, P., Candotti, F., et al. (2022) B Cell-T Cell Interplay in Immune Regulation: A Focus on Follicular Regulatory T and Regulatory B Cell Functions. Frontiers in Cell and Developmental Biology, 10, Article 991840.
https://doi.org/10.3389/fcell.2022.991840
[36] 齐亚丽, 苟晶琦, 余来顺, 等. 肺康颗粒结合噻托溴铵粉吸入剂对慢性阻塞性肺疾病Thl7/Treg平衡的调节作用[J]. 中华中医药学刊, 2021, 39(7): 188-191.